Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Congenital Abnormalities 3Blast Crisis 3Uterine Cervical Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Myelodysplastic Syndromes 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia 2Glioblastoma 2Anemia, Refractory, with Excess of Blasts 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Adenocarcinoma 1Neuroendocrine Tumors 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

tremelimumab 2fludarabine 2durvalumab 2aflibercept 2Trastuzumab 2Radiotherapy 2Radiosurgery 2Cyclophosphamide 2Cisplatin 2tipifarnib 1sapropterin 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1Vaccines 1Topotecan 1Therapeutics 1Radiation 1Platinum 1Pharmacogenomic Testing 1Papillomavirus Vaccines 1Nelfinavir 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunoglobulin G 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gemcitabine 1Ganciclovir 1E6 protein, Human papillomavirus type 16 1Docetaxel 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Vulvar Neoplasms × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all
NCT00335998 2013-01-11

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡